Literature DB >> 11351349

Mxi1, a Myc antagonist, suppresses proliferation of DU145 human prostate cells.

M M Taj1, R J Tawil, L D Engstrom, Z Zeng, C Hwang, M G Sanda, D S Wechsler.   

Abstract

BACKGROUND: Mxi1, an antagonist of c-Myc, maps to human chromosome 10q24-q25, a region altered in a substantial fraction of prostate tumors. Mice deficient for Mxi1 exhibit significant prostate hyperplasia. We studied the ability of Mxi1 to act as a growth suppressor in prostate tumor cells.
METHODS: We infected DU145 prostate carcinoma cells with an Mxi1-expressing adenovirus (AdMxi1) in vitro, and measured Mxi1 expression, cell proliferation, soft agar colony formation, and cell cycle distribution. To explore mechanisms of Mxi1-induced growth arrest, we performed gene expression analysis.
RESULTS: AdMxi1 infection resulted in reduced cell proliferation, reduced soft agar colony formation, and a higher proportion of cells in the G(2)/M phase of the cell cycle. This G(2)/M growth arrest was associated with elevated levels of cyclin B, and reduced levels of c-MYC and MDM2.
CONCLUSIONS: The ability of AdMxi1 to suppress prostate tumor cell proliferation supports a role for Mxi1 loss in the pathogenesis of a subset of human prostate cancers. Prostate 47:194-204, 2001. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11351349     DOI: 10.1002/pros.1063

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  23 in total

1.  Transcriptomic classification of antitumor agents: application to the analysis of the antitumoral effect of SR31747A.

Authors:  Jean-Bernard Ferrini; Omar Jbilo; Annick Peleraux; Therese Combes; Hubert Vidal; Sylvaine Galiegue; Pierre Casellas
Journal:  Gene Expr       Date:  2003

2.  Integration of genetic signature and TNM staging system for predicting the relapse of locally advanced colorectal cancer.

Authors:  Junjie Peng; Zhimin Wang; Wei Chen; Yin Ding; Haifeng Wang; Hongjie Huang; Wei Huang; Sanjun Cai
Journal:  Int J Colorectal Dis       Date:  2010-08-13       Impact factor: 2.571

Review 3.  New insights into the tumor metastatic process revealed by gene expression profiling.

Authors:  Patricia S Steeg
Journal:  Am J Pathol       Date:  2005-05       Impact factor: 4.307

4.  Induction of Mxi1-SR alpha by FOXO3a contributes to repression of Myc-dependent gene expression.

Authors:  Oona Delpuech; Beatrice Griffiths; Philip East; Abdelkader Essafi; Eric W-F Lam; Boudewijn Burgering; Julian Downward; Almut Schulze
Journal:  Mol Cell Biol       Date:  2007-04-23       Impact factor: 4.272

Review 5.  Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis.

Authors:  Daniel Diolaiti; Lisa McFerrin; Patrick A Carroll; Robert N Eisenman
Journal:  Biochim Biophys Acta       Date:  2014-05-22

6.  N-Myc differentially regulates expression of MXI1 isoforms in neuroblastoma.

Authors:  Michael B Armstrong; Rajen J Mody; D Christian Ellis; Adam B Hill; David A Erichsen; Daniel S Wechsler
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

7.  MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer.

Authors:  Shahana Majid; Sharanjot Saini; Altaf A Dar; Hiroshi Hirata; Varahram Shahryari; Yuichiro Tanaka; Soichiro Yamamura; Koji Ueno; Mohd Saif Zaman; Kamaldeep Singh; Inik Chang; Guoren Deng; Rajvir Dahiya
Journal:  Cancer Res       Date:  2011-02-17       Impact factor: 12.701

8.  Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530.

Authors:  Y-M Chang; L Bai; S Liu; J C Yang; H-J Kung; C P Evans
Journal:  Oncogene       Date:  2008-08-04       Impact factor: 9.867

9.  Motility-related actinin alpha-4 is associated with advanced and metastatic ovarian carcinoma.

Authors:  Maria V Barbolina; Brian P Adley; David L Kelly; Angela J Fought; Denise M Scholtens; Lonnie D Shea; M Sharon Stack
Journal:  Lab Invest       Date:  2008-03-24       Impact factor: 5.662

Review 10.  Cellular quiescence in mammary stem cells and breast tumor stem cells: got testable hypotheses?

Authors:  David C Harmes; James DiRenzo
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-02-25       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.